News

UK MHRA Approval Received For First-In-Human Trial Of Rincell-1, A First-In-Class Regenerative Cell Therapy For Sensorineural Hearing Loss
Rincell-1 addresses a multi $Bn global market opportunity where no disease modifying treatments currently existSheffield, July 01, 2025 (GL ...